PT1015444E - Derivados de pirimidina e processos para a sua preparacao - Google Patents

Derivados de pirimidina e processos para a sua preparacao

Info

Publication number
PT1015444E
PT1015444E PT98911242T PT98911242T PT1015444E PT 1015444 E PT1015444 E PT 1015444E PT 98911242 T PT98911242 T PT 98911242T PT 98911242 T PT98911242 T PT 98911242T PT 1015444 E PT1015444 E PT 1015444E
Authority
PT
Portugal
Prior art keywords
processes
preparation
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
PT98911242T
Other languages
English (en)
Inventor
Jong Wook Lee
Bong Yong Lee
Chang Seop Kim
Seung Kyu Lee
Keun Seog Song
Song Jin Lee
Woo Jeon Shim
Man Soon Hwang
Original Assignee
Yuhan Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp Ltd filed Critical Yuhan Corp Ltd
Publication of PT1015444E publication Critical patent/PT1015444E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT98911242T 1997-03-27 1998-03-24 Derivados de pirimidina e processos para a sua preparacao PT1015444E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970010863 1997-03-27
KR19970010862 1997-03-27

Publications (1)

Publication Number Publication Date
PT1015444E true PT1015444E (pt) 2003-10-31

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98911242T PT1015444E (pt) 1997-03-27 1998-03-24 Derivados de pirimidina e processos para a sua preparacao

Country Status (22)

Country Link
US (1) US6352993B1 (pt)
EP (1) EP1015444B1 (pt)
JP (1) JP3176379B2 (pt)
KR (1) KR100278857B1 (pt)
CN (1) CN1118464C (pt)
AR (1) AR012181A1 (pt)
AT (1) ATE241613T1 (pt)
AU (1) AU720385B2 (pt)
BR (1) BR9808070A (pt)
CA (1) CA2284795C (pt)
DE (1) DE69815126T2 (pt)
DK (1) DK1015444T3 (pt)
ES (1) ES2200324T3 (pt)
HK (1) HK1026418A1 (pt)
HU (1) HUP0000851A3 (pt)
IN (1) IN188411B (pt)
PT (1) PT1015444E (pt)
RU (1) RU2203894C2 (pt)
TR (1) TR199902383T2 (pt)
TW (1) TW542831B (pt)
UY (1) UY24938A1 (pt)
WO (1) WO1998043968A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
AU2003254282A1 (en) 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
WO2005009980A1 (en) * 2003-07-22 2005-02-03 Neurogen Corporation Substituted pyridin-2-ylamine analogues
AU2004283751B2 (en) * 2003-10-24 2011-05-19 Exelixis, Inc. p70S6 kinase modulators and method of use
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
JP2009511548A (ja) * 2005-10-14 2009-03-19 ノイロサーチ アクティーゼルスカブ 新規ピリミジン−2,4−ジアミン誘導体及び小コンダクタンスのカルシウム依存性カリウムチャネルのモジュレーターとしてのこれらの使用
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
EP2308877B1 (en) 2008-08-05 2014-01-22 Daiichi Sankyo Company, Limited Imidazopyridin-2-one derivatives
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
BR112013011737A2 (pt) 2010-11-15 2016-08-09 Univ Leuven Kath composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
IN2013MN01519A (pt) * 2011-02-25 2015-06-12 Yuhan Corp
MX2014009933A (es) * 2012-02-17 2015-12-16 Abbvie Inc Diaminopirimidinas utiles como inhibidores del virus sincitial respiratorio humano (rsv).
US9309271B2 (en) 2012-05-29 2016-04-12 Momentive Performance Materials Gmbh Preparation of isocyanato silanes
PE20151413A1 (es) 2012-11-21 2015-10-23 Ptc Therapeutics Inc Inhibidores de bmi-1 de pirimidina inversa sustituida
KR20150130491A (ko) 2013-03-13 2015-11-23 제넨테크, 인크. 피라졸로 화합물 및 그것의 용도
AR093580A1 (es) 2013-08-30 2015-06-10 Ptc Therapeutics Inc Inhibidores bmi-1 de pirimidina sustituidos
EP3055301B1 (en) 2013-10-07 2019-11-20 Kadmon Corporation, LLC (2-(5-isoindolin-2-yl)pyrimidin-4-yl)-amine derivatives as rho kinase inhibitors for treating autoimmune diseases
EP3071553A4 (en) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
JP2018502900A (ja) * 2014-10-22 2018-02-01 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム ジスコイジンドメイン受容体1を標的化する小分子阻害剤およびその使用
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
RS63286B1 (sr) * 2016-01-04 2022-06-30 ObsEva SA Istovremeno davanje alfa-amino estra hidroksipropiltiazolidin karboksamidnog derivata i tokolitičkog agensa
EP3606915A1 (de) * 2017-04-05 2020-02-12 Bayer CropScience Aktiengesellschaft 2-amino-5-oxyalkyl-pyrimidinderivate und deren verwendung zur bekämpfung unerwünschten pflanzenwachstums
WO2020055544A2 (en) 2018-08-17 2020-03-19 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
TR25912A (tr) 1989-03-22 1993-11-01 Ciba Geigy Ag 2-ANILIN-PRIMIDIN TüREVLERI BU MADDELERINELDE EDIL MELERI VE ZARARLILARA KARSI MüCADELEDE KULLANILMA- LARI
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
CA2095213A1 (en) 1990-11-06 1992-05-07 Jotham W. Coe Quinazoline derivatives for enhancing antitumor activity
EP0580753B1 (en) 1991-04-17 1995-03-01 Pfizer Inc. Pyrimidine derivatives for enhancing antitumor activity
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
EP0640599B1 (en) 1993-08-26 1998-03-04 Ono Pharmaceutical Co., Ltd. 4-Aminopyrimidine derivatives
WO1995010506A1 (en) 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
WO1996005177A1 (en) 1994-08-13 1996-02-22 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
CN1097591C (zh) 1996-05-04 2003-01-01 株式会社柳韩洋行 制备嘧啶衍生物的方法

Also Published As

Publication number Publication date
JP2000513014A (ja) 2000-10-03
TR199902383T2 (xx) 2000-06-21
HUP0000851A1 (hu) 2001-04-28
HK1026418A1 (en) 2000-12-15
AR012181A1 (es) 2000-09-27
CN1118464C (zh) 2003-08-20
WO1998043968A1 (en) 1998-10-08
BR9808070A (pt) 2000-03-08
DE69815126T2 (de) 2004-04-08
KR19980080789A (ko) 1998-11-25
IN188411B (pt) 2002-09-21
ATE241613T1 (de) 2003-06-15
CN1251586A (zh) 2000-04-26
US6352993B1 (en) 2002-03-05
UY24938A1 (es) 2001-01-31
JP3176379B2 (ja) 2001-06-18
DE69815126D1 (de) 2003-07-03
CA2284795A1 (en) 1998-10-08
EP1015444A1 (en) 2000-07-05
CA2284795C (en) 2004-01-20
EP1015444B1 (en) 2003-05-28
KR100278857B1 (ko) 2001-01-15
AU6523998A (en) 1998-10-22
AU720385B2 (en) 2000-06-01
DK1015444T3 (da) 2003-08-18
ES2200324T3 (es) 2004-03-01
HUP0000851A3 (en) 2002-04-29
TW542831B (en) 2003-07-21
RU2203894C2 (ru) 2003-05-10

Similar Documents

Publication Publication Date Title
PT1015444E (pt) Derivados de pirimidina e processos para a sua preparacao
PT874846E (pt) Derivados de purina e processos para a sua preparacao
BR9605919A (pt) Catalisadores e processos para sua preparação
NO20001776D0 (no) Medikamenter
PT994956E (pt) Regiao reguladora preferida por tecido masculino e metodo para a sua utilizacao
PT1005446E (pt) Derivados de n-aroilfenilalanina
PT915088E (pt) Derivados de d-prolina
NO980546D0 (no) Farmasöytiske midler
PT1113965E (pt) Acessorio para gargalo de garrafa
DE69805807D1 (de) Mikrobiozide n-sulfonylglycin-alkynyloxyphenethylamid-derivate
BR9507666A (pt) Novos derivados de pirimidina
PT1027362E (pt) Derivados de cetolidos 2-halogeno-6-o-substituidos
PT9493T (pt) Cabeca para esfregona
PT903339E (pt) Bifenilsulfonilcianamidas processos para a sua preparacao e sua utilizacao como medicamentos
DE69524611D1 (de) Pyrimidon-derivate
DE69801856D1 (de) Befestigungselement
PT939083E (pt) Complexos de ferro-succinilcaseina procedimento para sua preparacao e suas composicoes farmaceuticas
DE59805315D1 (de) Wasserlösliche chinacridone
NO970503D0 (no) Hudpreparat
PT966437E (pt) Derivados de 5-aroilnaftaleno
DE59813712D1 (de) Transponder
PT102095B (pt) Composicao de accao prolongada de granulos contendo 4-nitro-2-fenoximetanosulfonilida e processo para a sua preparacao
DE59805373D1 (de) Nephroprotektive Arzneimittel
KR970059635U (ko) 장구줄 조임구
BR9708461A (pt) Derivados de butadieno e processos para sua preparação